Startups

Sr Director, Commercial Finance

Definium Therapeutics · Remote · Remote

← All jobs
About Definium Therapeutics

Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.

About the role

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

What they're looking for

  • Bachelor's degree in Finance, Accounting, Economics, Business, or a related field, MBA, CPA, or CFA preferred
  • Minimum 10 years of progressive finance experience, including significant FP&A and commercial finance leadership experience
  • Experience supporting commercial organizations within the pharmaceutical, biotechnology, or life sciences industries
  • Experience supporting commercial readiness activities, product launches, revenue forecasting, and market access planning
  • Strong understanding of pharmaceutical commercialization, pricing, reimbursement, and gross-to-net forecasting
  • Advanced financial modeling, forecasting, and analytical skills
More about this role

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...

Read the full posting on Definium Therapeutics's site ↗

Finance

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.